From Surf Wiki (app.surf) — the open knowledge base
Substituted phenethylamine
Chemical class of organic compounds
Chemical class of organic compounds
| Field | Value |
|---|---|
| Image | Phenylethyl Amine General Formula V1.svg |
| ImageClass | skin-invert-image |
| Alt | Phenethylamine structure diagram |
| Caption | The structural formula of phenethylamine with marked substitution points. Phenethylamine is obtained when |
| R2=R3=R4=R5=R6=RN=Rα=Rβ=H. | |
| Chemical_class | Substituted derivatives of phenethylamine |
R2=R3=R4=R5=R6=RN=Rα=Rβ=H.
Substituted phenethylamines (or simply phenethylamines) are a chemical class of organic compounds that are based upon the phenethylamine structure; the class is composed of all the derivative compounds of phenethylamine which can be formed by replacing, or substituting, one or more hydrogen atoms in the phenethylamine core structure with substituents. Phenylethylamines are also generally found to be central nervous system stimulants with many also being entactogens/empathogens, and hallucinogens.
Structural classification
The structural formula of any substituted phenethylamine contains a phenyl ring that is joined to an amino (NH) group via a two-carbon sidechain. Hence, any substituted phenethylamine can be classified according to the substitution of hydrogen (H) atoms on phenethylamine's phenyl ring, sidechain, or amino group with a specific group of atoms. Several classes of substances can be considered phenylethylamine derivatives such as Substituted amphetamines, where there is a methyl group substituted at the alpha position on the ethyl chain, Substituted methylenedioxyphenethylamines, where a methylenedioxy group is joined at the 3 and 4 positions on the phenyl ring, and Substituted cathinones, which have a carbonyl group substituted at the beta position on the ethyl chain, most of which also have a methyl group substituted at the alpha positioning making most cathinones substituted amphetamines as well.
Pharmacology
Most substituted phenethylamines are psychoactive drugs which belong to a variety of different drug classes, including central nervous system stimulants (e.g., amphetamine), hallucinogens (e.g., 3,4,5-trimethoxyphenethylamine a.k.a. mescaline, 2,5-dimethoxy-4-methylamphetamine DOM), entactogen (e.g. MDA), appetite suppressants (e.g. phentermine), nasal decongestants and bronchodilators (e.g., levomethamphetamine and pseudoephedrine), antidepressants (e.g. bupropion and phenelzine), antiparkinson agents (e.g., selegiline), and vasopressors (e.g., ephedrine), among others. Many of these psychoactive compounds exert their pharmacological effects primarily by modulating monoamine neurotransmitter systems; however, there is no known mechanism of action or biological target that is common to all members of this subclass.
Examples
Numerous endogenous compounds – including hormones, catecholamines such as dopamine and noradrenaline, and many trace amines (e.g. adrenaline, phenethylamine itself, tyramine, thyronamine, and iodothyronamine) – are substituted phenethylamines. Several notable recreational drugs, such as MDPV (Monkey Dust), MDMA (ecstasy), methamphetamine, and cathinone, are also members of the class. Many well-known prescription drugs are from the phenylethylamine class such as Adderall which uses Amphetamine, Desoxyn which uses methamphetamine, and Sudafed which uses pseudoephedrine.
List of substituted phenethylamines
| Structure | Short Name | *RN* | *Rα* | *Rβ* | *R2* | *R3* | *R4* | *R5* | Full Name | Biologic activity | Short Name | *RN* | *Rα* | *Rβ* | *R2* | *R3* | *R4* | *R5* | Full Name | Biologic activity | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| [[File:Meta-Tyramine.svg | class=skin-invert-image | 120x120px]] | *meta*-Tyramine | OH | 3-hydroxyphenethylamine | Trace amine | ||||||||||||||||
| [[File:Tyramine.svg | class=skin-invert-image | 120x120px]] | *para*-Tyramine | OH | 4-hydroxyphenethylamine | Trace amine | ||||||||||||||||
| [[File:Dopamine.svg | class=skin-invert-image | 120x120px]] | Dopamine | OH | OH | 3,4-dihydroxyphenethylamine | Catecholamine neurotransmitter | |||||||||||||||
| [[File:Epinephrine.svg | class=skin-invert-image | 120x120px]] | Epinephrine (Adrenaline) | CH3 | OH | OH | OH | β,3,4-trihydroxy-*N*-methylphenethylamine | Catecholamine neurotransmitter/Fight or Flight hormone | |||||||||||||
| [[File:Norepinephrine.svg | class=skin-invert-image | 120x120px]] | Norepinephrine (Noradrenaline) | OH | OH | OH | β,3,4-trihydroxyphenethylamine | Catecholamine neurotransmitter/Fight or Flight hormone | ||||||||||||||
| [[File:Norfenefrine.png | class=skin-invert-image | 120x120px]] | Norfenefrine | OH | OH | β,3-dihydroxyphenethylamine | Trace amine | |||||||||||||||
| [[File:Octapamine.svg | class=skin-invert-image | 120x120px]] | para-Octopamine | OH | OH | β,4-dihydroxyphenethylamine | Trace aminergic α-adrenoceptor agonist | |||||||||||||||
| [[File:6-Hydroxydopamine.svg | class=skin-invert-image | 120x120px]] | [Oxidopamine](6-hydroxydopamine) | OH | OH | OH | 2,4,5-trihydroxyphenethylamine | neurotoxic agent for the dopamine and norepinephrine receptors | ||||||||||||||
| [[File:Phenylephrine v2.svg | class=skin-invert-image | 120x120px]] | Phenylephrine | CH3 | OH | OH | β,3-dihydroxy-*N*-methylphenethylamine | α-adrenergic agonist; decongestant | ||||||||||||||
| [[File:Isoprenaline.svg | class=skin-invert-image | 120x120px]] | Isoprenaline | CH(CH3)2 | OH | OH | OH | β,3-dihydroxy-*N*-isopropylphenethylamine | β-adrenergic agonist; decongestant | |||||||||||||
| [[File:Salbutamol.svg | class=skin-invert-image | 120x120px]] | Salbutamol | C(CH3)3 | OH | CH2OH | OH | β,4-dihydroxy-3-hydroxymethyl-*N*-*tert*-butylphenethylamine | Short-action β2-adrenergic agonist | |||||||||||||
| [[File:Beta-methylphenethylamine.png | class=skin-invert-image | 120x120px]] | β-Methylphenethylamine | CH3 | β-methylphenethylamine | Stimulant | ||||||||||||||||
| [[File:Amphetamine.svg | class=skin-invert-image | 120x120px]] | Amphetamine | CH3 | α-methylphenethylamine | Monoamine releasing agent; Stimulant | ||||||||||||||||
| [[File:Methylphenethylamine.png | class=skin-invert-image | 120x120px]] | *N*-Methylphenethylamine | CH3 | *N*-methylphenethylamine | Trace amine; endogenous amphetamine isomer | ||||||||||||||||
| [[File:N,N-Dimethylphenethylamine.svg | class=skin-invert-image | 120x120px]] | *N*,*N*-Dimethylphenethylamine | (CH3)2 | *N*,*N*-dimethylphenethylamine | Trivial effects (used as a food additive and flavoring agent) | ||||||||||||||||
| [[File:Methamphetamine.svg | class=skin-invert-image | 120x120px]] | Methamphetamine | CH3 | CH3 | *N*-methylamphetamine; *N*,α-dimethylphenethylamine | Monoamine releasing agent; stimulant; neurotoxin | |||||||||||||||
| [[File:Fentermina.svg | class=skin-invert-image | 120x120px]] | Phentermine | (CH3)2 | α-methylamphetamine; α,α-dimethylphenethylamine | Stimulant, anorectic | ||||||||||||||||
| [[File:2-methylamphetamine.svg | class=skin-invert-image | 120x120px]] | Ortetamine | CH3 | CH3 | 2-methylamphetamine; 2,α-dimethylphenethylamine | Stimulant, anorectic | |||||||||||||||
| [[File:Phenelzine.svg | class=skin-invert-image | 120x120px]] | Phenelzine | NH2 | β-phenylethylhydrazine | Monoamine oxidase inhibitor | ||||||||||||||||
| [[File:Tranylcypromine Structure.svg | class=skin-invert-image | 120x120px]] | Tranylcypromine | -CH2- | 2-phenylcyclopropylamine | Monoamine oxidase inhibitor | ||||||||||||||||
| [[File:Selegiline.svg | class=skin-invert-image | 120x120px]] | Selegiline | -CH2-C≡CH | CH3 | *N*,α-dimethyl-*N*-2-propynylphenethylamine | MAO-B selective monoamine oxidase inhibitor | |||||||||||||||
| [[File:Methylphenidate-2D-skeletal.svg | class=skin-invert-image | 120x120px]] | Methylphenidate | -CH2-CH2-CH2-CH2- | C(OCH3)=O | *N*,α-butylene-β-methoxycarbonylphenethylamine | NDRI; Stimulant | |||||||||||||||
| [[File:Ephedrine-ifa.png | class=skin-invert-image | 120x120px]] | Ephedrine / Pseudoephedrine | CH3 | CH3 | OH | *N*-methyl-β-hydroxyamphetamine | Releasing agent; stimulant; decongestant | ||||||||||||||
| [[File:Pseudonorephedrine.png | class=skin-invert-image | 120x120px]] | Cathine | CH3 | OH | d-β-hydroxyamphetamine | Moderately selective norepinephrine releasing agent | |||||||||||||||
| [[File:Cathinone.svg | class=skin-invert-image | 120x120px]] | Cathinone | CH3 | =O | β-ketoamphetamine | Selective norepinephrine and dopamine releasing agent | |||||||||||||||
| [[File:Methcathinone skeletal.svg | class=skin-invert-image | 120x120px]] | Methcathinone | CH3 | CH3 | =O | *N*-methylcathinone | Selective norepinephrine and dopamine releasing agent | ||||||||||||||
| [[File:Mephedrone-2D-skeletal.svg | class=skin-invert-image | 120x120px]] | Mephedrone | CH3 | CH3 | =O | CH3 | 4-methylmethcathinone | Stimulant, unknown pharmacodynamic actions | |||||||||||||
| [[File:Ethcathinone.svg | class=skin-invert-image | 120x120px]] | Ethcathinone | CH2CH3 | CH3 | =O | *N*-ethylcathinone | Stimulant and norepinephrine releasing agent | ||||||||||||||
| [[File:Amfepramone.svg | class=skin-invert-image | 120x120px]] | Amfepramone (diethylpropion) | C2H5, C2H5Two ethyl groups attached to the amine group | CH3 | =O | N-diethyl-β-ketoamphetamine | Anorectic | ||||||||||||||
| [[File:Bupropion 1.svg | class=skin-invert-image | 120x120px]] | Bupropion | C(CH3)3 | CH3 | =O | Cl | 5-chloro-*N*-*tert*-butyl-β-ketoamphetamine | NDRI | |||||||||||||
| [[File:3-trifluoromethylamphetamine.svg | class=skin-invert-image | 120x120px]] | Norfenfluramine | CH3 | CF3 | 3-trifluoromethyl-amphetamine | SSRA | |||||||||||||||
| [[File:Fenfluramine2DCSD.svg | class=skin-invert-image | 120x120px]] | Fenfluramine | CH2CH3 | CH3 | CF3 | 3-trifluoromethyl-*N*-ethylamphetamine | SSRA | ||||||||||||||
| [[File:5APB.svg | class=skin-invert-image | 120x120px]] | [5-APB](5-2-aminopropyl-benzofuran) | CH3 | -CH=CH-O- | 5-(2-aminopropyl)benzofuran | Stimulant, entactogen | |||||||||||||||
| [[File:6APB.svg | class=skin-invert-image | 120x120px]] | [6-APB](6-2-aminopropyl-benzofuran) | CH3 | -O-CH=CH- | 6-(2-aminopropyl)benzofuran | Stimulant, entactogen | |||||||||||||||
| [[File:MDA-2D-skeletal.svg | class=skin-invert-image | 120x120px]] | [MDA](3-4-methylenedioxyamphetamine) | CH3 | -O-CH2-O- | 3,4-methylenedioxy-amphetamine | Stimulant, psychedelic, entactogen | |||||||||||||||
| [[File:MDEA.svg | class=skin-invert-image | 120x120px]] | MDEA | CH2CH3 | CH3 | -O-CH2-O- | 3,4-methylenedioxy-*N*-ethylamphetamine | Psychedelic, entactogen, and releasing agent | ||||||||||||||
| [[File:MDMA (simple).svg | class=skin-invert-image | 120x120px]] | MDMA | CH3 | CH3 | -O-CH2-O- | 3,4-methylenedioxy-*N*-methylamphetamine | Psychedelic, entactogen, and releasing agent | ||||||||||||||
| [[File:MDMC.svg | class=skin-invert-image | 120x120px]] | MDMC | CH3 | CH3 | =O | -O-CH2-O- | 3,4-methylenedioxymethcathinone | Psychedelic, entactogen, and releasing agent | |||||||||||||
| [[File:5-methoxy-MDA.svg | class=skin-invert-image | 120x120px]] | MMDA | CH3 | -O-CH2-O- | OCH3 | 5-methoxy-3,4-methylenedioxy-amphetamine | Stimulant, psychedelic and entactogen | ||||||||||||||
| [[File:MMDMA.svg | class=skin-invert-image | 120x120px]] | MMDMA | CH3 | CH3 | -O-CH2-O- | OCH3 | 5-methoxy-3,4-methylenedioxy-*N*-methylamphetamine | Psychedelic, entactogen, and releasing agent | |||||||||||||
| [[File:Lophophine.png | class=skin-invert-image | 120x120px]] | Lophophine | -O-CH2-O- | OCH3 | 5-methoxy-3,4-methylenedioxyphenethylamine | Psychedelic and entactogen | |||||||||||||||
| [[File:Mescaline Structural Formulae bondline.svg | class=skin-invert-image | 120x120px]] | Mescaline | OCH3 | OCH3 | OCH3 | 3,4,5-trimethoxyphenethylamine | Psychedelic and entactogen | ||||||||||||||
| [[File:Proscaline.svg | class=skin-invert-image | 120x120px]] | Proscaline | OCH3 | OCH2CH2CH3 | OCH3 | 2-(3,5-dimethoxy-4-propoxyphenyl)ethanamine | Psychedelic and entactogen | ||||||||||||||
| [[File:Metaescaline.svg | class=skin-invert-image | 120x120px]] | Metaescaline | OCH2CH3 | OCH3 | OCH3 | 2-(3-ethoxy-4,5-dimethoxyphenyl)ethanamine | Psychedelic and entactogen | ||||||||||||||
| [[File:Allylescaline.svg | class=skin-invert-image | 120x120px]] | Allylescaline | OCH3 | OCH2CH1CH2 | OCH3 | 4-Allyloxy-3,5-dimethyloxyphenylethylamine | Psychedelic and entactogen | ||||||||||||||
| [[File:Methallylescaline.svg | class=skin-invert-image | 120x120px]] | Methallylescaline | OCH3 | OCH2C(CH2CH3) | OCH3 | 4-Methallyloxy-3,5-dimethoxyphenethylamine | Psychedelic and entactogen | ||||||||||||||
| [[File:Asymbescaline.svg | class=skin-invert-image | 120x120px]] | Asymbescaline | OCH2CH3 | OCH2CH3 | OCH3 | 3,4-Diethoxy-5-methoxyphenethylamine | Psychedelic and euphoriant | ||||||||||||||
| [[File:2,5-dimethoxy-4-methylamphetamine.svg | class=skin-invert-image | 120x120px]] | [DOM](2-5-dimethoxy-4-methylamphetamine) | CH3 | OCH3 | CH3 | OCH3 | 2,5-dimethoxy-4-methylamphetamine | Psychedelic | |||||||||||||
| [[File:2,5-dimethoxy-4-bromoamphetamine.svg | class=skin-invert-image | 119x119px]] | [DOB](2-5-dimethoxy-4-bromoamphetamine) | CH3 | OCH3 | Br | OCH3 | 2,5-dimethoxy-4-bromoamphetamine | Psychedelic | |||||||||||||
| [[File:2,5-dimethoxy-4-chloroamphetamine.svg | class=skin-invert-image | 120x120px]] | [DOC](2-5-dimethoxy-4-chloroamphetamine) | CH3 | OCH3 | Cl | OCH3 | 2,5-dimethoxy-4-chloroamphetamine | Psychedelic | |||||||||||||
| [[File:2,5-dimethoxy-4-iodoamphetamine.svg | class=skin-invert-image | 120x120px]] | [DOI](2-5-dimethoxy-4-iodoamphetamine) | CH3 | OCH3 | I | OCH3 | 2,5-dimethoxy-4-iodoamphetamine | Psychedelic | |||||||||||||
| [[File:2,5-dimethoxy-4-nitroamphetamine.svg | class=skin-invert-image | 120x120px]] | [DON](2-5-dimethoxy-4-nitroamphetamine) | CH3 | OCH3 | NO2 | OCH3 | 2,5-dimethoxy-4-nitroamphetamine | Stimulant | |||||||||||||
| [[File:2C-B.svg | class=skin-invert-image | 120x120px]] | [2C-B](2c-b) | OCH3 | Br | OCH3 | 2,5-dimethoxy-4-bromophenethylamine | Psychedelic, stimulant, entactogen and euphoriant | ||||||||||||||
| [[File:Βk-2C-B.svg | class=skin-invert-image | 120x120px]] | βk-2C-B | =O | OCH3 | Br | OCH3 | 2,5-dimethoxy-4-bromo-β-ketophenethylamine | Psychedelic, stimulant, entactogen and euphoriant | |||||||||||||
| [[File:2C-C-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-C](2c-c) | OCH3 | Cl | OCH3 | 2,5-dimethoxy-4-chlorophenethylamine | Psychedelic | ||||||||||||||
| [[File:2C-F-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-F](2c-f) | OCH3 | F | OCH3 | 2,5-dimethoxy-4-fluorophenethylamine | Psychedelic | ||||||||||||||
| [[File:2C-I-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-I](2c-i) | OCH3 | I | OCH3 | 2,5-dimethoxy-4-iodophenethylamine | Psychedelic, stimulant | ||||||||||||||
| [[File:2C-D 2DACS.svg | class=skin-invert-image | 120x120px]] | [2C-D](2c-d) | OCH3 | CH3 | OCH3 | 2,5-dimethoxy-4-methylphenethylamine | Psychedelic, stimulant | ||||||||||||||
| [[File:2C-E-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-E](2c-e) | OCH3 | CH2-CH3 | OCH3 | 2,5-dimethoxy-4-ethylphenethylamine | Psychedelic | ||||||||||||||
| [[File:2C-P-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-P](2c-p) | OCH3 | CH2-CH3-CH3 | OCH3 | 2,5-dimethoxy-4-propylphenethylamine | Entactogen, euphoriant and Psychedelic | ||||||||||||||
| [[File:2C-N 2DACS.svg | class=skin-invert-image | 120x120px]] | [2C-N](2c-n) | OCH3 | NO2 | OCH3 | 2,5-dimethoxy-4-nitrophenethylamine | euphoriant | ||||||||||||||
| [[File:2C-O-4-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-O-4](2c-o-4) | OCH3 | (CH3)2CHO | OCH3 | 2,5-Dimethoxy-4-propoxyphenethylamine | Hallucinogen, psychedelic and entheogenic | ||||||||||||||
| [[File:2C-T-2-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-T-2](2c-t-2) | OCH3 | S-CH2CH3 | OCH3 | 2,5-dimethoxy-4-ethylthio-phenethylamine | Psychedelic | ||||||||||||||
| [[File:2C-T-4-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-T-4](2c-t-4) | OCH3 | S-CH(CH3)2 | OCH3 | 2,5-dimethoxy-4-isopropylthio-phenethylamine | Psychedelic | ||||||||||||||
| [[File:2C-T-7-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-T-7](2c-t-7) | OCH3 | S-CH2CH2CH3 | OCH3 | 2,5-dimethoxy-4-propylthio-phenethylamine | Psychedelic | ||||||||||||||
| [[File:2C-T-8-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-T-8](2c-t-8) | OCH3 | S-CH2-C3H5 | OCH3 | 2,5-dimethoxy-4-cyclopropylmethylthio-phenethylamine | Psychedelic | ||||||||||||||
| [[File:2C-T-19.png | class=skin-invert-image | 120x120px]] | [2C-T-19](2c-t-19) | OCH3 | S-C(CH3)3 | OCH3 | 2,5-dimethoxy-4-*tert*-butylthio-phenethylamine | Psychedelic | ||||||||||||||
| [[File:2C-T-21-Chemdraw.png | class=skin-invert-image | 120x120px]] | [2C-T-21](2c-t-21) | OCH3 | S-CH2-CH2-F | OCH3 | 2,5-dimethoxy-4-(2-fluoroethylthio)-phenethylamine | Psychedelic and euphoriant | ||||||||||||||
| [[File:2C-B-NBOMe-skeletal.svg | class=skin-invert-image | 120x120px]] | [25B-NBOMe](25b-nbome) | CH2-C6H4-OCH3 | OCH3 | Br | OCH3 | 2-(4-bromo-2,5-dimethoxyphenyl)-*N*-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic | |||||||||||||
| [[File:2C-C-NBOMe-skeletal.svg | class=skin-invert-image | 120x120px]] | [25C-NBOMe](25c-nbome) | CH2-C6H4-OCH3 | OCH3 | Cl | OCH3 | 2-(4-chloro-2,5-dimethoxyphenyl)-*N*-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic | |||||||||||||
| [[File:25F-NBOMe structure.png | class=skin-invert-image | 120x120px]] | [25F-NBOMe](25f-nbome) | CH2-C6H4-OCH3 | OCH3 | F | OCH3 | 2-(4-fluoro-2,5-dimethoxyphenyl)-*N*-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic | |||||||||||||
| [[File:2C-I-NBOMe-skeletal.svg | class=skin-invert-image | 120x120px]] | [25I-NBOMe](25i-nbome) | CH2-C6H4-OCH3 | OCH3 | I | OCH3 | 2-(4-iodo-2,5-dimethoxyphenyl)-*N*-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic | |||||||||||||
| [[File:25D-NBOMe2DACS.svg | class=skin-invert-image | 120x120px]] | [25D-NBOMe](25d-nbome) | CH2-C6H4-OCH3 | OCH3 | CH2 | OCH3 | 2-(4-methyl-2,5-dimethoxyphenyl)-*N*-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic | |||||||||||||
| [[File:2C-E-NBOMe 2DACS.svg | class=skin-invert-image | 120x120px]] | [25E-NBOMe](25e-nbome) | CH2-C6H4-OCH3 | OCH3 | CH2-CH3 | OCH3 | 2-(4-ethyl-2,5-dimethoxyphenyl)-*N*-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic | |||||||||||||
| [[File:25P-NBOMe.svg | class=skin-invert-image | 120x120px]] | [25P-NBOMe](25p-nbome) | CH2-C6H4-OCH3 | OCH3 | CH2-CH3-CH3 | OCH3 | 2-(4-propyl-2,5-dimethoxyphenyl)-*N*-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic | |||||||||||||
| [[File:Mescaline-NBOMe.svg | class=skin-invert-image | 120x120px]] | Mescaline-NBOMe | CH2-C6H4-OCH3 | OCH3 | OCH3 | OCH3 | *N*-(2-Methoxybenzyl)-2-(3,4,5-trimethoxyphenyl)ethanamine | Psychedelic | |||||||||||||
| [[File:25B-NBOH structure.png | class=skin-invert-image | 120x120px]] | [25B-NBOH](25b-nboh) | CH2–C6H4–OH | OCH3 | Br | OCH3 | *N*-(2-hydroxybenzyl)-2,5-dimethoxy-4-bromo-phenethylamine | Psychedelic | |||||||||||||
| [[File:NBOH-2CC structure.png | class=skin-invert-image | 120x120px]] | [25C-NBOH](25c-nboh) | CH2–C6H4–OH | OCH3 | Cl | OCH3 | *N*-(2-hydroxybenzyl)-2,5-dimethoxy-4-chloro-phenethylamine | Psychedelic | |||||||||||||
| [[File:2C-I-NBOH-skeletal.svg | class=skin-invert-image | 120x120px]] | [25I-NBOH](25i-nboh) | CH2–C6H4–OH | OCH3 | I | OCH3 | *N*-(2-hydroxybenzyl)-2,5-dimethoxy-4-iodo-phenethylamine | Psychedelic | |||||||||||||
| [[File:25i-NBF.svg | class=skin-invert-image | 120x120px]] | [25I-NBF](25i-nbf) | CH2–C6H4–F | OCH3 | I | OCH3 | *N*-(2-fluorobenzyl)-2,5-dimethoxy-4-iodo-phenethylamine | Psychedelic |
Detection
| Method | Requirement |
|---|---|
| UV spectrometry | Reagent needed |
Detection of substituted phenethylamines, which include compounds such as 2C-B, MDMA, and other designer drugs, involves various analytical methods aimed at identifying these psychoactive substances. These compounds are structurally similar to amphetamines, making their detection challenging due to potential cross-reactivity in standard drug tests. Techniques like gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), and immunoassay screenings are commonly employed for accurate identification. Advanced methods like high-performance liquid chromatography (HPLC) allow for precise separation and quantification of these substances even at low concentrations. Given the rising use of these drugs in recreational settings, developing sensitive and specific detection techniques remains crucial in forensic toxicology and clinical diagnostics.
Cyclized phenethylamines
There are many cyclized phenethylamines. Examples include the following:
- Phenylalkylpyrrolidines like PEP, MPEP, prolintane, α-PPP, α-PVP, pyrovalerone, and MDPV
- Phenylalkylpiperidines like AC927 (phenethylpiperidine), diphenidine, fentanyl, and ifenprodil
- Tetrahydroisoquinolines (THIQs) like anhalinine, pellotine, lophophorine, DOM-CR, nomifensine, tetrabenazine, and zelandopam
- Isoquinolines like perafensine, quinisocaine, and tilisolol
- Dihydroindoles and aminochromes like adrenochrome and adrenolutin
- 2-Aminoindanes (2-AIs) like 2-aminoindane, MDAI, MMAI, DOM-AI, and Pyr-AI
- 2-Aminotetralins (2-ATs) like 2-aminotetralin, MDAT, DOM-AT, 8-OH-DPAT, and rotigotine
- 1-Aminomethylindanes (1-AMIs) like 2CB-Ind, AMMI, jimscaline, and bromojimscaline
- 3-Benzazepines like fenoldopam and lorcaserin
- Benzocyclobutenes (BCBs) like 2CBCB-NBOMe, S33005, TCB-2, tomscaline, and bromotomscaline
- Tetrahydrobenzopyranylamines like CT-5126
- Benzoxepins like TFMBOX
- 2-Benzylpiperidines and phenidates like 2-benzylpiperidine, methylphenidate, rimiterol, and DMBMPP
- Phenylcyclopropylamines like tranylcypromine, TMT, and DMCPA
- 3-Phenylpiperidines (3PIPs) like 3-phenylpiperidine, 3-PPP, OSU-6162 (PNU-96391), LPH-5, LPH-48, 2C-B-3PIP, 2C-B-3PIP-NBOMe, 2C-B-3PIP-POMe, and Z3517967757 (Z7757)
- 2-Phenylmorpholines like 2-phenylmorpholine, phenmetrazine, manifaxine, radafaxine, flumexadol, oxaflozane, and PF-219,061
- Phenyloxazolamines or aminorex analogues like aminorex and pemoline
- Tricyclic compounds like benzoctamine and dizocilpine
- Ergolines and lysergamides like ergine (LSA) and LSD
- Partial ergolines and lysergamides like NDTDI, RU-27849, DEIMDHPCA, and DEMPDHPCA
- Pyridopyrroloquinoxalines like lumateperone, IHCH-7113, IHCH-7086, and ITI-1549
- Others like 6-AB, 2-ADN, 2C-B-PYR, 2C-B-5-hemiFLY-α6 (BNAP), 2CB7 (2C-B-5-hemiFLY-β7), 2CBecca, 2CJP, 2CLisaB, 2CLisaH, 2-naphthylamine, GYKI-52895, ivabradine, milnacipran, Org 6582, and ZC-B
Some additional cyclized phenethylamines have also been described.{{cite web | vauthors=Wolters RJ | title=Synthesis of Conformationally Constrained Analogs of Mescaline as Potential Psychotomimetics
Other related families that are not phenethylamines themselves include phenylpiperazines, benzylpiperazines, and 4-phenylpiperidines.
Notes
References
References
- (April 2020). "Novel Phenethylamines and Their Potential Interactions With Prescription Drugs: A Systematic Critical Review". Therapeutic Drug Monitoring.
- (9 March 2012). "Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants". Wiley.
- {{CitePiHKAL [http://www.erowid.org/library/books_online/pihkal/pihkal035.shtml 2C-O-4 Entry in PiHKAL]
- (November 2020). "25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential". Addiction Biology.
- (August 1981). "Structure-activity relationships of phenethylamine hallucinogens". J Pharm Sci.
- (September 1974). "Conformationally constrained analogs of mescaline". J Pharm Sci.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Substituted phenethylamine — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report